Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 395)
Posted On: 09/28/2020 2:43:18 AM
Post# of 36567
Posted By: pacsurg21
Hi all, perhaps I can be of some help on putting this opportunity into perspective:

I’m not sure about what margins GNBT has for this, but we are in the industry (medical) and the market range for revenues as it applies to our CPT codes reimbursement in relationship to the device cost is a range between 15%-25% of the govt reimbursement being spent on our 1-device.

In regard to SAAS, we pay approximately 1.5% for annual license for the business software we use in relation to our revenues. Just sharing for perspective purposes. 25% I believe is a reasonable assumption on gross revenues, especially considering the potential for direct charging and the relatively low per transaction cost.

Excited for this week, Go GNBT!!













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site